Physician profile
Ryan E Lee
NPI 1932570470
$5,081.03
in general payments reported to CMS, 2019-2025
46 companies · $866 in 2025
The $866 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $870 · 2022: $911 · 2023: $1,355 · 2024: $1,078 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,299.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $419.52 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $415.71 | 2022-2025 | |
| Urogen Pharma, INC. | $347.45 | 2023-2024 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $345.79 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $255.54 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $181.50 | 2021-2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $180.44 | 2023-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $178.96 | 2021-2024 | Xiaflex |
| Medtronic, INC. | $159.08 | 2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $155.45 | 2021-2024 | |
| Rochester Medical Corporation | $146.52 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $134.63 | 2021-2024 | Lynparza |
| Eisai INC. | $133.19 | 2021-2025 | |
| Blue Earth Diagnostics | $129.21 | 2022-2024 | |
| Progenics Pharmaceuticals, INC. | $125.73 | 2022-2025 | Pylarify |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $119.68 | 2022 | |
| Abbvie INC. | $107.54 | 2022-2025 | |
| Procept Biorobotics Corporation | $105.94 | 2023 | Aquabeam Robotic System |
| Tolmar, INC. | $104.79 | 2023-2025 | Rubraca, Jatenzo |
| Janssen Biotech, INC. | $104.73 | 2021-2023 | Erleada |
| Endo USA, INC. | $103.67 | 2024-2025 | Xiaflex |
| Verity Pharmaceuticals INC. | $97.09 | 2025 | Trelstar, Tlando |
| Laborie Medical Technologies Corp. | $86.84 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Myovant Sciences INC. | $78.99 | 2021-2022 | |
| Astellas Pharma US INC | $69.14 | 2021-2024 | Veozah |
| Coloplast Corp | $60.03 | 2022-2024 | Speedicath |
| Genzyme Corporation | $55.90 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $54.83 | 2021 | |
| Seagen INC. | $54.71 | 2021-2023 | Padcev |
| Boston Scientific Corporation | $52.93 | 2024-2025 | Ams 700, Rezum Generator |
| Urovant Sciences INC | $50.71 | 2022 | |
| Daiichi Sankyo INC. | $48.26 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $46.63 | 2023 | |
| Caris Mpi, INC. | $46.60 | 2025 | Mi Cancer Seek |
| Ferring Pharmaceuticals INC. | $42.82 | 2023-2025 | Adstiladrin |
| Accord Healthcare, INC. | $35.44 | 2024 | |
| Exelixis INC. | $35.23 | 2023-2024 | Cabometyx |
| Merck Sharp & Dohme LLC | $31.83 | 2023 | Lynparza, Keytruda, Welireg |
| Pharmaand Gmbh | $31.13 | 2025 | Rubraca |
| Convatec INC. | $28.64 | 2025 | |
| Clarus Therapeutics INC. | $26.19 | 2021 | |
| 180 Medical, INC. | $23.02 | 2024 | Gentlecath |
| Olympus America INC. | $20.80 | 2023 | Itind System |
| Tolmar Pharmaceuticals, INC. | $18.71 | 2021 | |
| Acerus Pharmaceuticals Corporation | $15.48 | 2022 | |
| Emd Serono, INC. | $14.01 | 2023 | Bavencio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.